Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Kosmidis, PA
Kalofonos, C
Syrigos, K
Skarlos, D
Fountzilas, G
Nicolaides, C
Bafaloukos, D
Samantas, E
Bakogiannis, C
Dimopoulos, AM
机构：
[1] Hygeia Hosp, Athens, Greece
[2] Hosp Patra, Patras, Greece
[3] SOTIRIA Hosp, Athens, Greece
[4] Errikos Dunan Hosp, Athens, Greece
[5] Ahepa Hosp, Thessaloniki, Greece
[6] Ioannina Hosp, Ioannina, Greece
[7] Metropolitan Hosp, Piraeus, Greece
[8] Agioi Anargyroi Hosp, Athens, Greece
[9] Alexandra Hosp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：621S / 621S
页数：1
相关论文
共 50 条
  • [41] Carboplatin plus gemcitabine followed by weekly paclitaxel in advanced and metastatic non-small cell lung cancer (NSCLC): A phase II study
    Tjan-Heijnen, V
    Timmer-Bonte, J
    van der Drift, M
    van Leeuwen, F
    de Boo, T
    Wagenaar, M
    van Die, L
    Bussink, J
    LUNG CANCER, 2005, 49 : S272 - S272
  • [42] Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results
    Kosmidis, P
    Mylonakis, N
    Dimopoulos, A
    Pavlidis, N
    Fountzilas, G
    Samantas, E
    Dimitriadis, K
    Kalophonos, C
    Tsavdaridis, D
    Skarlos, D
    SEMINARS IN ONCOLOGY, 2000, 27 (01) : 3 - 8
  • [43] A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer
    Ansari, Rafat H.
    Socinski, Mark A.
    Edelman, Martin J.
    Belani, Chandra P.
    Gonin, Rene
    Catalano, Robert B.
    Marinucci, Donna M.
    Comis, Robert L.
    Obasaju, Coleman K.
    Chen, Ruqin
    Monberg, Matthew J.
    Treat, Joseph
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (02) : 162 - 171
  • [44] Gemcitabine (GEM) and carboplatin (CARB) in elderly patients with advanced non-small cell lung cancer (NSCLC): Subset analysis of a randomized phase II trial.
    Masters, GA
    Nickolov, A
    Hahn, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 679S - 679S
  • [45] Randomized phase II trial of irinotecan combined with paclitaxel or gemcitabine in untreated advanced non-small cell lung cancer
    Kinoshita, A.
    Fukuda, M.
    Nagashima, S.
    Fukuda, M.
    Takatani, H.
    Nakano, H.
    Nakamura, Y.
    Oka, M.
    Soda, H.
    Kohno, S.
    EJC SUPPLEMENTS, 2007, 5 (04): : 382 - 382
  • [46] Phase I study of gemcitabine (GEM) and carboplatin (CBDCA) in advanced non-small cell lung cancer (NSCLC).
    Kawabata, S
    Oka, M
    Fukuda, M
    Kinoshita, A
    Fukuda, M
    Nagashima, S
    Nakamura, Y
    Nakano, H
    Soda, H
    Kohno, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 688S - 688S
  • [47] Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer
    Burris, HA
    Hainsworth, JD
    Erland, JB
    Morrissey, LH
    Kalman, LA
    Hon, JK
    Scullin, DC
    Smith, SW
    Greco, FA
    SEMINARS IN ONCOLOGY, 2000, 27 (01) : 9 - 13
  • [48] Phase II study of weekly carboplatin/gemcitabine plus concurrent thoracic radiotherapy (RT) followed by consolidation carboplatin/gemcitabine for inoperable stage III non-small cell lung cancer (NSCLC).
    Domine, Manuel
    Carames Sanchez, Cristina
    Lobo, Francisco
    Hernandez Guerrero, Tatiana Carolina
    Leon, Ana
    Casado, Victoria
    Rubio, Gustavo
    Ignacio Martin-Valades, Jose
    Izarzugaza, Yann
    Luis Arranz, Juan
    Moreno, Irene
    Correa Noguera, Andrea
    Zenzola, Victor
    Dorta, Miriam
    Casado, Susana
    Ruperez, Ana
    Hernandez Lopez, Roberto
    Moreno, Victor
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC)
    Lee Siow-Ming
    Woll, Penella J.
    Rudd, Robin M.
    Gower, Nicole H.
    Ottensmeier, Christian H.
    Ali, Kulsam
    Spiro, Stephen G.
    Hackshaw, Allan
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S359 - S359
  • [50] Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer
    J. R. Kroep
    E. F. Smit
    G. Giaccone
    K. Van der Born
    J. H. Beijnen
    C. J. Van Groeningen
    W. J. F. Van der Vijgh
    P. E. Postmus
    H. M. Pinedo
    G. J. Peters
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 509 - 516
12345